{"meta":{"query_hash":"35fdf2586a7e","filters":{"venue":"Blood Science"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/35fdf2586a7e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Blood+Science"},"results":[{"id":"W4415854905","doi":"10.1097/bs9.0000000000000257","title":"Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025)","year":2025,"lang":"en","type":"article","venue":"Blood Science","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Genetic enhancement; Factor IX; Virus; Hemostasis; Disease; Adeno-associated virus","score_opus":0.02688209653721419,"score_gpt":0.3889697775975102,"score_spread":0.36208768106029604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415854905","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008164875,0.1408288,0.04210259,0.23695588,0.01709313,0.007435724,0.009598561,0.0032841244,0.5345363],"genre_scores_gemma":[0.057003975,0.12808293,0.10114469,0.19391215,0.0068719927,0.01212467,0.016637888,0.0009389626,0.48328272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647707,0.0009106673,0.00039486177,0.00020391696,0.0017061633,0.00030732428],"domain_scores_gemma":[0.99729425,0.0007400701,0.0002702367,0.00016884744,0.0011453913,0.00038119368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00535176,0.0007017078,0.0008955342,0.0011975898,0.00086385227,0.0013765653,0.0012821472,0.0058208345,0.026957126],"category_scores_gemma":[0.0059522986,0.0004875963,0.0014075502,0.00086575537,0.0011772302,0.0008392544,0.0012752429,0.003301443,0.012025006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014539051,0.0001307844,0.0007162742,0.0011119717,0.000033476703,0.0006678174,0.00022919496,0.00025024565,0.0038668003,0.011302058,0.7301728,0.25137314],"study_design_scores_gemma":[0.0001181902,0.000100387384,0.0017006757,0.00032158478,0.000032793763,0.00057324837,0.0000249838,0.00018331598,0.0006059399,0.001192865,0.99512476,0.000021164482],"about_ca_topic_score_codex":0.019685268,"about_ca_topic_score_gemma":0.023973707,"teacher_disagreement_score":0.026957126,"about_ca_system_score_codex":0.0018697451,"about_ca_system_score_gemma":0.014796505,"threshold_uncertainty_score":0.090180576},"labels":[],"label_agreement":null}]}